Rani Therapeutics Holdsing s (RANI) PT Lowered to $9 at Canaccord Genuity on 'pushed back projected launch of RT-102'
Tweet Send to a Friend
(Updated - March 27, 2024 6:47 AM EDT)
Canaccord Genuity analyst Edward Nash lowered the price target on Rani ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash lowered the price target on Rani ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
